2017 annual financial data
Voyager Therapeutics 2017 Operating margin
Direct answer
Operating margin was -709.06%.
Operating income was -71,863,000 USD and net income was -70,698,000 USD.
Operating cash flow was -61,350,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,135,000 USD
- Operating income
- -71,863,000 USD
- Net income
- -70,698,000 USD
- Operating cash flow
- -61,350,000 USD